NCT03947606: Pilot Optimization Trial of Decision Partnering Intervention for Advanced Cancer Family Caregivers

Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Active, not recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must have been diagnosed within 60-90 days of initial pre-screening with an advanced cancer defined as metastatic, recurrent, or progressive stage IV cancer

Comments are closed.

Up ↑